nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—bone cancer	0.886	1	CbGaD
Tolvaptan—Vismodegib—SMO—bone cancer	0.00933	0.684	CrCbGaD
Tolvaptan—Neurological symptom—Cisplatin—bone cancer	0.00506	0.0501	CcSEcCtD
Tolvaptan—Conivaptan—CYP3A4—bone cancer	0.00193	0.141	CrCbGaD
Tolvaptan—Prothrombin level increased—Epirubicin—bone cancer	0.00191	0.019	CcSEcCtD
Tolvaptan—Prothrombin level increased—Doxorubicin—bone cancer	0.00177	0.0175	CcSEcCtD
Tolvaptan—Hyperuricaemia—Cisplatin—bone cancer	0.00165	0.0163	CcSEcCtD
Tolvaptan—Blood uric acid increased—Cisplatin—bone cancer	0.00156	0.0154	CcSEcCtD
Tolvaptan—Hyperkalaemia—Cisplatin—bone cancer	0.0015	0.0149	CcSEcCtD
Tolvaptan—Hypernatraemia—Epirubicin—bone cancer	0.00149	0.0148	CcSEcCtD
Tolvaptan—Body temperature increased—Carboplatin—bone cancer	0.00147	0.0146	CcSEcCtD
Tolvaptan—Hypernatraemia—Doxorubicin—bone cancer	0.00138	0.0137	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Methotrexate—bone cancer	0.00138	0.0137	CcSEcCtD
Tolvaptan—Zafirlukast—CYP3A4—bone cancer	0.00129	0.0943	CrCbGaD
Tolvaptan—Polyuria—Cisplatin—bone cancer	0.00126	0.0125	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Cisplatin—bone cancer	0.00113	0.0112	CcSEcCtD
Tolvaptan—Hyponatraemia—Cisplatin—bone cancer	0.00111	0.011	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.00111	0.011	CcSEcCtD
Tolvaptan—Vismodegib—CYP3A4—bone cancer	0.00109	0.0799	CrCbGaD
Tolvaptan—Vaginal haemorrhage—Epirubicin—bone cancer	0.00106	0.0105	CcSEcCtD
Tolvaptan—Blood creatinine increased—Cisplatin—bone cancer	0.00104	0.0103	CcSEcCtD
Tolvaptan—Dehydration—Cisplatin—bone cancer	0.00103	0.0102	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Cisplatin—bone cancer	0.00101	0.01	CcSEcCtD
Tolvaptan—Breast disorder—Cisplatin—bone cancer	0.001	0.00993	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000998	0.0099	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Doxorubicin—bone cancer	0.000981	0.00972	CcSEcCtD
Tolvaptan—Hyperuricaemia—Methotrexate—bone cancer	0.000904	0.00896	CcSEcCtD
Tolvaptan—Respiratory failure—Methotrexate—bone cancer	0.000854	0.00846	CcSEcCtD
Tolvaptan—Blood uric acid increased—Methotrexate—bone cancer	0.000854	0.00846	CcSEcCtD
Tolvaptan—Hyperuricaemia—Epirubicin—bone cancer	0.000846	0.00838	CcSEcCtD
Tolvaptan—Renal failure—Cisplatin—bone cancer	0.00084	0.00833	CcSEcCtD
Tolvaptan—Pulmonary embolism—Methotrexate—bone cancer	0.000838	0.00831	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Epirubicin—bone cancer	0.000829	0.00822	CcSEcCtD
Tolvaptan—Blood uric acid increased—Epirubicin—bone cancer	0.000799	0.00792	CcSEcCtD
Tolvaptan—Pulmonary embolism—Epirubicin—bone cancer	0.000784	0.00778	CcSEcCtD
Tolvaptan—Hyperuricaemia—Doxorubicin—bone cancer	0.000782	0.00776	CcSEcCtD
Tolvaptan—Hyperkalaemia—Epirubicin—bone cancer	0.000771	0.00764	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Doxorubicin—bone cancer	0.000767	0.00761	CcSEcCtD
Tolvaptan—Ecchymosis—Methotrexate—bone cancer	0.000758	0.00751	CcSEcCtD
Tolvaptan—Urine output increased—Methotrexate—bone cancer	0.000758	0.00751	CcSEcCtD
Tolvaptan—Urinary tract disorder—Cisplatin—bone cancer	0.000757	0.00751	CcSEcCtD
Tolvaptan—Connective tissue disorder—Cisplatin—bone cancer	0.000754	0.00747	CcSEcCtD
Tolvaptan—Urethral disorder—Cisplatin—bone cancer	0.000752	0.00745	CcSEcCtD
Tolvaptan—Blood uric acid increased—Doxorubicin—bone cancer	0.000739	0.00733	CcSEcCtD
Tolvaptan—Pulmonary embolism—Doxorubicin—bone cancer	0.000726	0.0072	CcSEcCtD
Tolvaptan—Hyperkalaemia—Doxorubicin—bone cancer	0.000713	0.00707	CcSEcCtD
Tolvaptan—Cardiac disorder—Cisplatin—bone cancer	0.000712	0.00706	CcSEcCtD
Tolvaptan—Ecchymosis—Epirubicin—bone cancer	0.000709	0.00703	CcSEcCtD
Tolvaptan—Polyuria—Methotrexate—bone cancer	0.000693	0.00687	CcSEcCtD
Tolvaptan—Immune system disorder—Cisplatin—bone cancer	0.000693	0.00687	CcSEcCtD
Tolvaptan—Mediastinal disorder—Cisplatin—bone cancer	0.000691	0.00685	CcSEcCtD
Tolvaptan—Malnutrition—Cisplatin—bone cancer	0.000668	0.00662	CcSEcCtD
Tolvaptan—Ecchymosis—Doxorubicin—bone cancer	0.000656	0.00651	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Methotrexate—bone cancer	0.000621	0.00616	CcSEcCtD
Tolvaptan—Ill-defined disorder—Cisplatin—bone cancer	0.00062	0.00614	CcSEcCtD
Tolvaptan—Malaise—Cisplatin—bone cancer	0.000602	0.00597	CcSEcCtD
Tolvaptan—Renal impairment—Epirubicin—bone cancer	0.000598	0.00593	CcSEcCtD
Tolvaptan—Hypoglycaemia—Epirubicin—bone cancer	0.000583	0.00578	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Epirubicin—bone cancer	0.000581	0.00576	CcSEcCtD
Tolvaptan—Hyponatraemia—Epirubicin—bone cancer	0.000572	0.00567	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000569	0.00565	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000565	0.0056	CcSEcCtD
Tolvaptan—Discomfort—Cisplatin—bone cancer	0.000562	0.00557	CcSEcCtD
Tolvaptan—Renal impairment—Doxorubicin—bone cancer	0.000554	0.00549	CcSEcCtD
Tolvaptan—Breast disorder—Methotrexate—bone cancer	0.00055	0.00545	CcSEcCtD
Tolvaptan—Anaphylactic shock—Cisplatin—bone cancer	0.000545	0.0054	CcSEcCtD
Tolvaptan—Hypoglycaemia—Doxorubicin—bone cancer	0.00054	0.00535	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Doxorubicin—bone cancer	0.000538	0.00533	CcSEcCtD
Tolvaptan—Nervous system disorder—Cisplatin—bone cancer	0.000534	0.0053	CcSEcCtD
Tolvaptan—Blood creatinine increased—Epirubicin—bone cancer	0.000533	0.00529	CcSEcCtD
Tolvaptan—Dehydration—Epirubicin—bone cancer	0.000529	0.00525	CcSEcCtD
Tolvaptan—Skin disorder—Cisplatin—bone cancer	0.000529	0.00525	CcSEcCtD
Tolvaptan—Hyponatraemia—Doxorubicin—bone cancer	0.000529	0.00524	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000527	0.00522	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Epirubicin—bone cancer	0.00052	0.00516	CcSEcCtD
Tolvaptan—Anorexia—Cisplatin—bone cancer	0.000519	0.00515	CcSEcCtD
Tolvaptan—Breast disorder—Epirubicin—bone cancer	0.000515	0.0051	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000513	0.00508	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000502	0.00498	CcSEcCtD
Tolvaptan—Blood creatinine increased—Doxorubicin—bone cancer	0.000494	0.00489	CcSEcCtD
Tolvaptan—Dehydration—Doxorubicin—bone cancer	0.00049	0.00486	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Doxorubicin—bone cancer	0.000481	0.00477	CcSEcCtD
Tolvaptan—Breast disorder—Doxorubicin—bone cancer	0.000476	0.00472	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000474	0.0047	CcSEcCtD
Tolvaptan—Decreased appetite—Cisplatin—bone cancer	0.000474	0.0047	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Cisplatin—bone cancer	0.00047	0.00466	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000465	0.00461	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—bone cancer	0.000461	0.00457	CcSEcCtD
Tolvaptan—Pollakiuria—Epirubicin—bone cancer	0.000455	0.00451	CcSEcCtD
Tolvaptan—Feeling abnormal—Cisplatin—bone cancer	0.000449	0.00445	CcSEcCtD
Tolvaptan—Hyperglycaemia—Epirubicin—bone cancer	0.000444	0.0044	CcSEcCtD
Tolvaptan—Renal failure—Epirubicin—bone cancer	0.000431	0.00428	CcSEcCtD
Tolvaptan—Body temperature increased—Cisplatin—bone cancer	0.000431	0.00427	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—bone cancer	0.000421	0.00417	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—bone cancer	0.000416	0.00412	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—bone cancer	0.000413	0.00409	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—bone cancer	0.000411	0.00407	CcSEcCtD
Tolvaptan—Hypersensitivity—Cisplatin—bone cancer	0.000401	0.00398	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—bone cancer	0.000399	0.00396	CcSEcCtD
Tolvaptan—Asthenia—Cisplatin—bone cancer	0.000391	0.00388	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—bone cancer	0.000391	0.00387	CcSEcCtD
Tolvaptan—Urinary tract disorder—Epirubicin—bone cancer	0.000389	0.00386	CcSEcCtD
Tolvaptan—Connective tissue disorder—Epirubicin—bone cancer	0.000387	0.00384	CcSEcCtD
Tolvaptan—Urethral disorder—Epirubicin—bone cancer	0.000386	0.00383	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—bone cancer	0.000382	0.00379	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—bone cancer	0.00038	0.00377	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—bone cancer	0.000379	0.00376	CcSEcCtD
Tolvaptan—Diarrhoea—Cisplatin—bone cancer	0.000373	0.0037	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—bone cancer	0.000366	0.00363	CcSEcCtD
Tolvaptan—Cardiac disorder—Epirubicin—bone cancer	0.000366	0.00362	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—bone cancer	0.00036	0.00357	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—bone cancer	0.000359	0.00356	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—bone cancer	0.000358	0.00355	CcSEcCtD
Tolvaptan—Angiopathy—Epirubicin—bone cancer	0.000357	0.00354	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—bone cancer	0.000357	0.00354	CcSEcCtD
Tolvaptan—Immune system disorder—Epirubicin—bone cancer	0.000356	0.00353	CcSEcCtD
Tolvaptan—Mediastinal disorder—Epirubicin—bone cancer	0.000355	0.00352	CcSEcCtD
Tolvaptan—Malnutrition—Epirubicin—bone cancer	0.000343	0.0034	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—bone cancer	0.00034	0.00337	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—bone cancer	0.000338	0.00335	CcSEcCtD
Tolvaptan—Dysgeusia—Epirubicin—bone cancer	0.000336	0.00333	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—bone cancer	0.000331	0.00328	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—bone cancer	0.00033	0.00328	CcSEcCtD
Tolvaptan—Immune system disorder—Doxorubicin—bone cancer	0.000329	0.00326	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—bone cancer	0.000328	0.00326	CcSEcCtD
Tolvaptan—Nausea—Cisplatin—bone cancer	0.000324	0.00321	CcSEcCtD
Tolvaptan—Ill-defined disorder—Epirubicin—bone cancer	0.000318	0.00315	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—bone cancer	0.000317	0.00315	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—bone cancer	0.000311	0.00308	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00031	0.00307	CcSEcCtD
Tolvaptan—Malaise—Epirubicin—bone cancer	0.000309	0.00307	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—bone cancer	0.000308	0.00306	CcSEcCtD
Tolvaptan—Syncope—Epirubicin—bone cancer	0.000307	0.00305	CcSEcCtD
Tolvaptan—Loss of consciousness—Epirubicin—bone cancer	0.000301	0.00299	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—bone cancer	0.000299	0.00296	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—bone cancer	0.000294	0.00292	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—bone cancer	0.000293	0.00291	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—bone cancer	0.00029	0.00288	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00029	0.00287	CcSEcCtD
Tolvaptan—Discomfort—Epirubicin—bone cancer	0.000288	0.00286	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—bone cancer	0.000286	0.00284	CcSEcCtD
Tolvaptan—Dry mouth—Epirubicin—bone cancer	0.000285	0.00283	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—bone cancer	0.000285	0.00283	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—bone cancer	0.000285	0.00282	CcSEcCtD
Tolvaptan—Anaphylactic shock—Epirubicin—bone cancer	0.00028	0.00277	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—bone cancer	0.000279	0.00276	CcSEcCtD
Tolvaptan—Shock—Epirubicin—bone cancer	0.000275	0.00273	CcSEcCtD
Tolvaptan—Nervous system disorder—Epirubicin—bone cancer	0.000274	0.00272	CcSEcCtD
Tolvaptan—Skin disorder—Epirubicin—bone cancer	0.000272	0.00269	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000268	0.00266	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—bone cancer	0.000267	0.00265	CcSEcCtD
Tolvaptan—Anorexia—Epirubicin—bone cancer	0.000267	0.00264	CcSEcCtD
Tolvaptan—Dry mouth—Doxorubicin—bone cancer	0.000264	0.00262	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—bone cancer	0.00026	0.00258	CcSEcCtD
Tolvaptan—Anaphylactic shock—Doxorubicin—bone cancer	0.000259	0.00257	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—bone cancer	0.000258	0.00256	CcSEcCtD
Tolvaptan—Shock—Doxorubicin—bone cancer	0.000255	0.00253	CcSEcCtD
Tolvaptan—Nervous system disorder—Doxorubicin—bone cancer	0.000254	0.00252	CcSEcCtD
Tolvaptan—Skin disorder—Doxorubicin—bone cancer	0.000252	0.00249	CcSEcCtD
Tolvaptan—Anorexia—Doxorubicin—bone cancer	0.000247	0.00245	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—bone cancer	0.000246	0.00244	CcSEcCtD
Tolvaptan—Decreased appetite—Epirubicin—bone cancer	0.000243	0.00241	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Epirubicin—bone cancer	0.000242	0.0024	CcSEcCtD
Tolvaptan—Constipation—Epirubicin—bone cancer	0.000239	0.00237	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—bone cancer	0.000236	0.00234	CcSEcCtD
Tolvaptan—Feeling abnormal—Epirubicin—bone cancer	0.000231	0.00229	CcSEcCtD
Tolvaptan—Decreased appetite—Doxorubicin—bone cancer	0.000225	0.00223	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000224	0.00222	CcSEcCtD
Tolvaptan—Constipation—Doxorubicin—bone cancer	0.000221	0.0022	CcSEcCtD
Tolvaptan—Body temperature increased—Epirubicin—bone cancer	0.000221	0.00219	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—bone cancer	0.00022	0.00218	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—bone cancer	0.000215	0.00213	CcSEcCtD
Tolvaptan—Feeling abnormal—Doxorubicin—bone cancer	0.000213	0.00212	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—bone cancer	0.000212	0.0021	CcSEcCtD
Tolvaptan—Hypersensitivity—Epirubicin—bone cancer	0.000206	0.00204	CcSEcCtD
Tolvaptan—Body temperature increased—Doxorubicin—bone cancer	0.000205	0.00203	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—bone cancer	0.000205	0.00203	CcSEcCtD
Tolvaptan—Asthenia—Epirubicin—bone cancer	0.000201	0.00199	CcSEcCtD
Tolvaptan—Pruritus—Epirubicin—bone cancer	0.000198	0.00196	CcSEcCtD
Tolvaptan—Dizziness—Methotrexate—bone cancer	0.000198	0.00196	CcSEcCtD
Tolvaptan—Diarrhoea—Epirubicin—bone cancer	0.000191	0.0019	CcSEcCtD
Tolvaptan—Hypersensitivity—Doxorubicin—bone cancer	0.000191	0.00189	CcSEcCtD
Tolvaptan—Headache—Methotrexate—bone cancer	0.000187	0.00186	CcSEcCtD
Tolvaptan—Asthenia—Doxorubicin—bone cancer	0.000186	0.00184	CcSEcCtD
Tolvaptan—Dizziness—Epirubicin—bone cancer	0.000185	0.00183	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—bone cancer	0.000183	0.00182	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—bone cancer	0.000178	0.00176	CcSEcCtD
Tolvaptan—Diarrhoea—Doxorubicin—bone cancer	0.000177	0.00176	CcSEcCtD
Tolvaptan—Headache—Epirubicin—bone cancer	0.000175	0.00174	CcSEcCtD
Tolvaptan—Dizziness—Doxorubicin—bone cancer	0.000171	0.0017	CcSEcCtD
Tolvaptan—Nausea—Epirubicin—bone cancer	0.000166	0.00165	CcSEcCtD
Tolvaptan—Headache—Doxorubicin—bone cancer	0.000162	0.00161	CcSEcCtD
Tolvaptan—Nausea—Doxorubicin—bone cancer	0.000154	0.00152	CcSEcCtD
